NEKTAR THERAPEUTICS — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M | SVP, COO & CFO | Award / Grant | 40,150 | — | — | 280,831 | Nov 15, 2021 |
| Brainard Diana | — | Award / Grant | 18,360 | — | — | 18,360 | Nov 11, 2021 |
| GREER R SCOTT | — | Option Exercise | 12,500 | $12.80 | $160,000 | 293,374 | Nov 9, 2021 |
| Ajer Jeffrey Robert | — | Award / Grant | 10,200 | — | — | 36,175 | Sep 22, 2021 |
| WHITFIELD ROY A | — | Award / Grant | 10,200 | — | — | 236,050 | Sep 22, 2021 |
| GREER R SCOTT | — | Award / Grant | 10,200 | — | — | 280,874 | Sep 22, 2021 |
| EASTHAM KARIN | — | Award / Grant | 10,200 | — | — | 34,300 | Sep 22, 2021 |
| Curet Myriam | — | Sale | 3,665 | $17.78 | $65,164 | 25,775 | Sep 22, 2021 |
| CHESS ROBERT | — | Sale | 4,600 | $17.94 | $82,524 | 279,873 | Sep 22, 2021 |
| WHITFIELD ROY A | — | Option Exercise | 40,000 | $13.80 | $552,000 | 225,850 | Sep 16, 2021 |
| CHESS ROBERT | — | Option Exercise | 8,000 | $13.80 | $110,400 | 282,273 | Sep 9, 2021 |
| GREER R SCOTT | — | Option Exercise | 45,000 | $12.70 | $571,500 | 270,674 | Aug 31, 2021 |
| CHESS ROBERT | — | Gift | 2,100 | — | — | 2,100 | Aug 24, 2021 |
| Zalevsky Jonathan | Chief R&D Officer | Sale | 7,662 | $13.83 | $105,965 | 212,803 | Aug 16, 2021 |
| Wilson Mark Andrew | SVP & General Counsel | Sale | 1,910 | $13.83 | $26,415 | 72,900 | Aug 16, 2021 |
| ROBIN HOWARD W | President & CEO | Sale | 11,515 | $13.83 | $159,252 | 424,123 | Aug 16, 2021 |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | Sale | 13,339 | $13.83 | $184,478 | 137,822 | Aug 16, 2021 |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | Sale | 6,192 | $13.83 | $85,635 | 200,915 | Aug 16, 2021 |
| Labrucherie Gil M | SVP, COO & CFO | Sale | 3,000 | $13.56 | $40,680 | 240,231 | Aug 16, 2021 |
| CHESS ROBERT | — | Option Exercise | 3,524 | $13.80 | $48,631 | 284,097 | Jul 20, 2021 |
| Zalevsky Jonathan | Chief R&D Officer | Sale | 31,111 | $18.30 | $569,331 | 235,065 | May 17, 2021 |
| Wilson Mark Andrew | SVP & General Counsel | Sale | 1,917 | $18.30 | $35,081 | 74,810 | May 17, 2021 |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | Sale | 13,391 | $18.30 | $245,055 | 151,161 | May 17, 2021 |
| ROBIN HOWARD W | President & CEO | Sale | 11,560 | $18.30 | $211,548 | 435,638 | May 17, 2021 |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | Sale | 6,085 | $18.30 | $111,356 | 207,107 | May 17, 2021 |
| Labrucherie Gil M | SVP, COO & CFO | Sale | 7,898 | $18.30 | $144,533 | 251,098 | May 17, 2021 |
| CHESS ROBERT | — | Sale | 8,000 | $19.34 | $154,720 | 280,573 | May 12, 2021 |
| CHESS ROBERT | — | Option Exercise | 8,000 | $13.80 | $110,400 | 288,573 | Apr 14, 2021 |
| Zalevsky Jonathan | Chief R&D Officer | Sale | 24,141 | $22.37 | $540,034 | 266,176 | Feb 16, 2021 |
| Wilson Mark Andrew | SVP & General Counsel | Sale | 2,173 | $22.37 | $48,610 | 76,727 | Feb 16, 2021 |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | Sale | 11,705 | $22.37 | $261,841 | 164,552 | Feb 16, 2021 |
| ROBIN HOWARD W | President & CEO | Sale | 11,495 | $22.37 | $257,143 | 447,198 | Feb 16, 2021 |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | Sale | 15,358 | $22.37 | $343,558 | 213,192 | Feb 16, 2021 |
| Labrucherie Gil M | SVP, COO & CFO | Sale | 7,977 | $22.37 | $178,445 | 258,996 | Feb 16, 2021 |
| Wilson Mark Andrew | SVP & General Counsel | Option Exercise | 5,344 | $8.80 | $47,027 | 84,244 | Feb 3, 2021 |
| Labrucherie Gil M | SVP, COO & CFO | Option Exercise | 25,000 | $8.80 | $220,000 | 291,973 | Feb 2, 2021 |
| ROBIN HOWARD W | President & CEO | Option Exercise | 75,000 | $8.80 | $660,000 | 608,693 | Feb 2, 2021 |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | Option Exercise | 37,500 | $8.80 | $330,000 | 213,757 | Jan 28, 2021 |
| GREER R SCOTT | — | Option Exercise | 40,000 | $13.80 | $552,000 | 225,674 | Jan 5, 2021 |
| WHITFIELD ROY A | — | Gift | 51,500 | — | — | 185,850 | Dec 30, 2020 |
| Zalevsky Jonathan | Chief R&D Officer | Award / Grant | 40,000 | — | — | 290,317 | Dec 18, 2020 |
| Wilson Mark Andrew | SVP & General Counsel | Award / Grant | 28,550 | — | — | 78,900 | Dec 18, 2020 |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | Award / Grant | 16,000 | — | — | 176,257 | Dec 18, 2020 |
| ROBIN HOWARD W | President & CEO | Award / Grant | 106,650 | — | — | 458,693 | Dec 18, 2020 |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | Award / Grant | 28,550 | — | — | 228,550 | Dec 18, 2020 |
| Labrucherie Gil M | SVP, COO & CFO | Award / Grant | 40,000 | — | — | 266,973 | Dec 18, 2020 |
| Myriam Curet | — | Sale | 1,560 | $17.82 | $27,799 | 19,240 | Dec 15, 2020 |
| Zalevsky Jonathan | Chief R&D Officer | Sale | 16,380 | $16.40 | $268,632 | 250,317 | Nov 23, 2020 |
| Zalevsky Jonathan | Chief R&D Officer | Sale | 29,618 | $16.93 | $501,433 | 266,697 | Nov 16, 2020 |
| Wilson Mark Andrew | SVP & General Counsel | Sale | 1,539 | $16.93 | $26,055 | 49,850 | Nov 16, 2020 |